Dr. Sunil K. Joshi, CEO, is a pioneering leader in biotechnology, immunology, and quantum pharmacology, driving revolutionary advancements in immunotherapy, personalized medicine, and the mathematical foundations of quantum physics in pharmaceuticals. With a PhD in Structural Immunology (Malaria Vaccines) from New Delhi (2000) and a Doctor of Veterinary Medicine (DVM) from India, Dr. Joshi’s research explores the interplay between immunology, emotional well-being, and quantum physics applications in pharmacology.
As a postdoctoral fellow, he focused on developing impactful immunological solutions, including groundbreaking discoveries on how Northern Lights populations exhibit emotional-immune system connections, where depression correlates with weakened immunity. A prolific researcher, he has authored 77 peer-reviewed publications and three scientific books, earning recognition from the American Society of Immunology and the American Society of Clinical Immunology.
Dr. Joshi dedicates his work to helping individuals thrive academically and professionally, often mentoring aspiring scientists across the globe. His deepest inspiration comes from his late father, whose tragic passing before Dr. Joshi's journey to the U.S. continues to fuel his commitment to scientific discovery and human progress.
Looking ahead, Dr. Joshi is committed to advancing quantum physics applications in pharmacology and expanding groundbreaking immunological therapies to transform healthcare globally. His ultimate goal is simple yet profound: “Help mankind.” Guided by a philosophy of thinking from every perspective, he continues to push the boundaries of science to create a lasting impact on the world.